Home › Research › Tau biomarkers
Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study
Nordlund A, Rolstad S, Klang O, Edman A, Hansen S, Wallin A.. Journal of neurology, neurosurgery, and psychiatry, 2009-12-03
Topic: Risk, prevention and care in population studies
Plain-language summary
Objective The objective was to study the 2-year outcome of subjects diagnosed as having mild cognitive impairment (MCI). Methods Two hundred and nine subjects diagnosed as having MCI were examined with a comprehensive neuropsychological test battery and followed up after 2 years. Results After 2 years, 34 subjects (16%) were lost for follow-up.
What this study adds
Evidence grade: Low
The record lists 34 participants. This study followed 209 people with mild cognitive impairment for two years to describe their outcomes, finding that 4.5% of those followed up improved to normal. Reported effect size: 4.5%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Nordlund, A., Rolstad, S., Klang, O., Edman, A., Hansen, S., & Wallin, A. (2010). Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp.2008.171066
Vancouver
Nordlund A, Rolstad S, Klang O, Edman A, Hansen S, Wallin A. Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study. Journal of neurology, neurosurgery, and psychiatry. 2010. doi:10.1136/jnnp.2008.171066. PMID: 19965857.
BibTeX
@article{nordlund2010-19965857,
author = {Nordlund, A. and Rolstad, S. and Klang, O. and Edman, A. and Hansen, S. and Wallin, A.},
title = {{Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study}},
journal = {Journal of neurology, neurosurgery, and psychiatry},
year = {2010},
doi = {10.1136/jnnp.2008.171066},
pmid = {19965857},
url = {https://doi.org/10.1136/jnnp.2008.171066}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Methods Two hundred and nine subjects diagnosed as having MCI were examined with a comprehensive neuropsychological test battery and followed up after 2 years.
- Results After 2 years, 34 subjects (16%) were lost for follow-up.
- Those subjects did not differ significantly in terms of MCI subclassification, MMSE score or age and education.
- Of the 175 subjects followed up, eight (4.5%) had improved to normal, two with amnestic MCI, one from multiple domains MCI, three with single domain MCI and two without any significant impairment at baseline.
Why it matters
This study followed 209 people with mild cognitive impairment for two years to describe their outcomes, finding that 4.5% of those followed up improved to normal. It is an observational outcome study and does not test any treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants34
- Effect size4.5%
- Evidence strengthLow
How this study scored 47/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of neurology, neurosurgery, and psychiatry) |
| Journal's citation record | 3 / 4 | Journal of Neurology Neurosurgery & Psychiatry: journal h-index 336 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2010 — within 20 year(s) of the newest study here |
| Sample size | 1 / 4 | 34 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 119 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 6.6 citations a year over 18 year(s) since 2010 |
| Impact for its field and year | 3 / 6 | Cited 5.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Anders Wallin: h-index 72 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Gothenburg: institution h-index 972 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 19965857) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 20.
Later studies that cite this one
5 studies in the alzhub library list this one in their references.
Related studies in Tau biomarkers from nearby years
Also in Tau biomarkers
61 studies in the library are filed under Tau biomarkers with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Tau biomarkers hub.